Takehara et al. reported that the intravenous administration of 3 mg/kg of rhTM 30 min prior to sepsis induction improved sepsis survival, and suppressed the elevation of inflammatory cytokines and HMGB1 in serum and ascites in an LPS-treated mouse sepsis model25. This evidence concerns the gene HMGB1 and Sepsis.